News

2012

A new prescription for medicine

19 January 2012

Cardiff medical students are set to work more closely with other healthcare students as part of a modern multiprofessional team so patients receive the safest possible care, according to the University’s new Senior Lecturer in Interprofessional Medical Education.

‘Killer cells’ and diabetes

16 January 2012

Killer T-cells in the human body which help protect us from disease can inadvertently destroy cells that produce insulin, new University research has uncovered.

Fellowship honour for Physiotherapist

16 January 2012

The Director of Postgraduate Healthcare Studies has been awarded a Fellowship from the Chartered Society of Physiotherapy in recognition of her outstanding contribution to the profession.

Rhys to the Rescue – Two

16 January 2012

Dr Rhys Jones, the emergency wildlife expert, is back.

Supporting A-level students

12 January 2012

Free revision sessions for local A-level students sitting their Chemistry and Physics exams have been run by the University.

Hadyn Ellis Building takes shape

12 January 2012

Construction of the University’s Hadyn Ellis Building is making significant progress at the Maindy Park site.

Chair of Council

11 January 2012

Former chairman of GE Healthcare Limited and senior operational leader of the largest medical research funder in the UK, Mr John Jeans has been appointed as Chair of the University’s Council.

Go Zambia

10 January 2012

An exhibition showcasing Africa-inspired art by children and professional artists has been unveiled designed to kick-start new medical links between Cardiff and Zambia.

Improving Welsh dental health

9 January 2012

Cardiff dental students will be providing treatment for hundreds of patients currently without a dentist at a new South Wales outreach unit.

Purchase deal over Hepatitis drug

9 January 2012

American pharmaceutical giant Bristol-Myers Squibb has agreed the purchase of US biotech company Inhibitex, in a $2.5Bn (£1.6bn) deal which includes the promising new anti-hepatitis C drug INX-189, first designed and prepared in Cardiff University.